[Newborn infants of mothers with endocrinopathies]

When pregnancy and endocrinological disease evolve together, the course of the endocrinological disease and/or the pregnancy and/or the development of the fetus can be altered. Pathophysiological interactions and their therapeutic consequences are reviewed regarding 21-hydroxylase deficiency congenital adrenal hyperplasia, ovary and adrenal virilizing tumours, Addison disease, primary hyperaldosteronism, pheochromocytoma, Graves' disease, Hashimoto thyroiditis, primary hypothyroidism, primary hypo- and hyperparathyroidism and bromocriptine treatment of hyperprolactinaemia.